Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022
October 01, 2022 19:03 ET
|
Belite Bio, Inc
LBS-008 (aka Tinlarebant) was safe and well tolerated in adolescent Stargardt Disease (STGD1) subjects at 12-month time pointThe majority of the subjects showed stabilization of BCVA in at least one...
Verizon deploys additional 5G Ultra Wideband to help with Hurricane Ian recovery
October 01, 2022 13:08 ET
|
Verizon Sourcing LLC
LEE COUNTY, Fla., Oct. 01, 2022 (GLOBE NEWSWIRE) -- In the wake of the most destructive hurricane to hit the Southwestern coast of Florida in decades, Verizon’s engineers are responding quickly to...
Verisk’s Geospatial Data, AI-Enhanced Analytics and Vexcel’s Aerial Imagery Combine to Help Accelerate Insurance Response to Historic Hurricane Damage
October 01, 2022 12:21 ET
|
Verisk Analytics, Inc.
JERSEY CITY, N.J., Oct. 01, 2022 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics provider, is working with Vexcel Data Program, the world’s largest aerial imagery program,...
Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Investigational Gene Therapy Botaretigene Sparoparvovec (AAV-RPGR) and Sustained Vision Improvement in Patients with X-Linked Retinitis Pigmentosa (XLRP)
October 01, 2022 10:00 ET
|
MeiraGTx
LONDON and NEW YORK, Oct. 01, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical-stage gene therapy company, announced today the primary...
Li Auto Inc. September 2022 Delivery Update
September 30, 2022 22:00 ET
|
Li Auto Inc.
BEIJING, China, Oct. 01, 2022 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company...
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2022 18:15 ET
|
Sarepta Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 30, 2022...
CSX Contributes $200,000 to Hurricane Ian Relief Efforts
September 30, 2022 17:57 ET
|
CSX Corporation
JACKSONVILLE, Fla., Sept. 30, 2022 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced it will contribute $200,000 to support relief and recovery efforts underway in the Florida and South...
Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
September 30, 2022 17:30 ET
|
Apellis Pharmaceuticals, Inc.
New analyses of microperimetry data showed positive trends with both monthly and every-other-month pegcetacoplan treatment near the GA lesion border compared to shamThese analyses provide further...
Allegiance Bancshares, Inc. and CBTX, Inc. Complete Merger of Equals to Become Stellar Bancorp, Inc.
September 30, 2022 17:02 ET
|
CommunityBank of Texas, N.A.
HOUSTON, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, and CBTX, Inc. (NASDAQ: CBTX) (“CBTX”), the holding...
Kaixin Auto Holdings Announces Receipt of Nasdaq Letter Regarding Minimum Bid Price
September 30, 2022 17:00 ET
|
Kaixin Auto Holdings
BEIJING, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) announces today the receipt of a notification letter (the “Nasdaq Letter”) dated September...